With preclinical studies of an in-development cholesterol-reducing medication now complete, Food and Drug Administration officials confirmed Monday they would be conducting initial trials of the new drug at a large party house they had rented in upstate Pennsylvania.According to the FDA, around a dozen researchers will participate in the experimental pharmaceuticalâ€™s weekend-long test, which is taking place in the Poconos at a 2,500-square-foot lakeside cottage the agency found on Airbnb.